✦ LIBER ✦

Continuous efficacy of etanercept in severe and advanced ankylosing spondylitis: results from a 12-week open-label extension of the SPINE study

✍ Scribed by Dougados, M.; Braun, J.; Szanto, S.; Combe, B.; Geher, P.; Leblanc, V.; Logeart, I.

Book ID: 118199214
Publisher: Oxford University Press
Year: 2012
Tongue: English
Weight: 430 KB
Volume: 51
Category: Article
ISSN: 1462-0324
DOI: 10.1093/rheumatology/kes125

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results from an open-label extension stu

Results from an open-label extension study of etanercept in ankylosing spondylitis

✍ Davis, John ;Webb, Allison ;Lund, Steven ;Sack, Kenneth 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

COPD ϭ chronic obstructive pulmonary disease. 300 Letters \* RA ϭ rheumatoid arthritis; JRA ϭ juvenile rheumatoid arthritis; ESR ϭ erythrocyte sedimentation rate; CRP ϭ C-reactive protein; VAS ϭ visual analog scale; GH ϭ general health; DAS28 ϭ Disease Activity Score in 28 joints; HAQ ϭ Health Asses

Long-Term Safety and Efficacy of Donepez

Long-Term Safety and Efficacy of Donepezil in Patients with Dementia with Lewy Bodies: Results from a 52-Week, Open-Label, Multicenter Extension Study

✍ Ikeda, Manabu; Mori, Etsuro; Kosaka, Kenji; Iseki, Eizo; Hashimoto, Mamoru; Mats 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 856 KB

P.4.006 Long-term efficacy and safety be

P.4.006 Long-term efficacy and safety benefits from treatment with the NMDA antagonist memantine: results of a 24-week, open-label extension study in moderate to severe Alzheimer's disease

✍ H.-J. Moebius; B. Reisberg; F. Schmitt; R. Doody 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 274 KB

Efficacy and safety of adalimumab for mo

Efficacy and safety of adalimumab for moderate to severe hidradenitis suppurativa: Results from the open-label phase of a 52-week phase II, randomized, study

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Long-Term Efficacy and Safety Profile of

Long-Term Efficacy and Safety Profile of Rilonacept in the Treatment of Cryopryin-Associated Periodic Syndromes: Results of a 72-Week Open-Label Extension Study

✍ Hoffman, Hal M.; Throne, Martin L.; Amar, Niran J.; Cartwright, Robert C.; Kivit 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 660 KB

Long-term efficacy and safety of adalimu

Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: Results from an open-label extension study for patients from REVEAL

✍ Kenneth Gordon; Kim Papp; Yves Poulin; Yihua Gu; Stephen Rozzo; Eric H. Sasso 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 347 KB